My point is that up to NASDAQ to uplist or not. They really dont have to do that if for some reason they dont like the company. Im here for CVSI but you cant go around and sue everybody
Is that a conspiracy theory or just the old victim card mentality. Look, there are many possible reasons that the uplisting hasn't occured yet. NASDAQ is very protective of their reputation and hence very selective of the companies they accept. They are privy to information that we regular folks don't have access to and we don't know what the conversation between CVSI and NAS has been. IMHO its a bit ridiculous to spout corruption just because of the delay. NAS has the right to delay or reject a company for any reason. Also the idea that we should or could sue the NASDAQ due to the delay is laughable and it just isn't going to happen in any way shape or form.
There are a myriad of reasons why there is and will be NO CVSI “uplist”
They are;
(1) Michael Mona III and his recent fine for fraud and being barred from being in any position with any public company for 5 years,
(2) CVSI relationship with John Fife (Iliad) a well known OTC toxic death spiral financier is yet another strike. Look at all the lawsuits and SEC regulatory fines and suspensions of Fife.
Fife himself was suspended by the SEC in August of 2007 which included his having to pay a hefty fine. The suspension was for a minimum 18 months before he could apply for reinstatement.
Fife works under numerous corporate veils. In addition to the Iliad LLC he used to loan CVSI money you will also find him making toxic, death spiral convertible dilutive loans under the names; Tonaquint, Tangiers, Chicago Ventures, JVF Holdings, Inter Mountain Capital I Inc and Utah Resources.
(2) NASDAQ Rule 5101. Listing may be denied for association with individuals with a history of regulatory misconduct. Fully applicable. Not only has CVSI been affiliated and led by Mona who clearly qualifies as having a recent history of regulatory misconduct with CVSI but CVSI also was financed by John Fife (“Iliad”) Fife has a long history of regulatory misconduct.
(3) In a statement, FDA Commissioner Scott Gottlieb, M.D. says the passage of the U.S. farm bill, now called the Agriculture Improvement Act of 2018 since it is law, does not diminish the agency's regulatory oversight role related to cannabis-containing food and drink. He says the FDA will be diligent in monitoring the hemp marketplace to ensure that makers of non-approved products are not making unsubstantiated medical claims. Also, the Food, Drug and Cosmetics Act prohibits interstate commerce of food containing cannabidiol (CBD) or tetrahydrocannabinol (THC) since it is an active ingredient in an FDA-approved drugs
News 
Market Data 
Discover 
